CCM

MKT CAP:$582456

Concord Medical Services Holdings Limited

Market Cap

$582456

Healthcare·Medical - Care Facilities·🇨🇳 China·NYSE

Healthcare·Medical·🇨🇳·NYSE

Stock Price

$3.92-$0.35 (-8.20%)

Apr 21, 2026

Company Details

Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its servi...

CEO

Jianyu Yang

IPO Date

Dec 11, 2009

Website

www.concordmedical.com

Key Metrics TTM

Revenue

$53M

-22.5% YoY

Net Income

-$24M

EPS (Diluted)

-$164.64

Free Cash Flow

$0

Revenue / Share

$367.02

Gross Margin

-11.4%

Operating Margin

-131.0%

Net Margin

-44.6%

FCF Margin

0.0%

P/S

0.0x

P/E

—

Earnings Reports

Q2 2025

Jun 30, 2025

$15M-8.3%EPS -$13.81

Q1 2025

Mar 31, 2025

$15M-8.3%EPS -$13.81

FY 2024

Apr 25, 2025

$56M-28.6%EPS -$309.30

Q4 2024

Apr 25, 2025

$12M-34.7%EPS -$68.51

Q3 2024

Sep 30, 2024

$12M-34.7%EPS -$68.51

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 21	$21M	-$4M	-$20M
Q4 21	$21M	-$4M	-$20M
Q1 22	$11M	-$6M	-$18M
Q2 22	$11M	-$6M	-$18M
Q3 22	$24M	-$5M	-$56M
Q4 22	$24M	-$5M	-$56M
Q1 23	$21M	-$3M	$16M
Q2 23	$21M	-$3M	$16M
Q3 23	$18M	-$3M	-$49M
Q4 23	$18M	-$3M	-$49M
Q1 24	$16M	-$3M	-$14M
Q2 24	$16M	-$3M	-$14M
Q3 24	$12M	-$3M	-$24M
Q4 24	$12M	-$3M	-$24M
Q1 25	$15M	-$312.9K	-$11M
Q2 25	$15M	-$312.9K	-$11M

Valuation

Quarter	P/S	P/E
Q3 21	0.0x	—
Q4 21	0.0x	—
Q1 22	0.0x	—
Q2 22	0.0x	—
Q3 22	0.0x	—
Q4 22	0.0x	—
Q1 23	0.0x	—
Q2 23	0.0x	—
Q3 23	0.0x	—
Q4 23	0.0x	—
Q1 24	0.0x	—
Q2 24	0.0x	—
Q3 24	0.0x	—
Q4 24	0.0x	—
Q1 25	0.0x	—
Q2 25	0.0x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 18	$0	$0
Q4 19	$0	$0
Q2 20	$0	$0
Q4 20	$0	$0
Q4 21	$0	$0
Q4 22	$0	$0
Q1 23	$0	$0
Q2 23	$0	$0
Q3 23	$0	$0
Q4 23	$0	$0
Q1 24	$0	$0
Q2 24	$0	$0
Q3 24	$0	$0
Q4 24	$0	$0
Q1 25	$0	$0
Q2 25	$0	$0

Capital Expenditures

Quarter	CapEx
Q4 18	$0
Q4 19	$0
Q2 20	$0
Q4 20	$0
Q4 21	$0
Q4 22	$0
Q1 23	$0
Q2 23	$0
Q3 23	$0
Q4 23	$0
Q1 24	$0
Q2 24	$0
Q3 24	$0
Q4 24	$0
Q1 25	$0
Q2 25	$0

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 21	+109.1%	+91.6%
Q4 21	+109.1%	+91.6%
Q1 22	-25.2%	+3.5%
Q2 22	-25.2%	+3.5%
Q3 22	+12.0%	+93.7%
Q4 22	+12.0%	+93.7%
Q1 23	+97.2%	-81.9%
Q2 23	+97.2%	-81.9%
Q3 23	-22.9%	-15.3%
Q4 23	-22.9%	-15.3%
Q1 24	-23.1%	+491.0%
Q2 24	-23.1%	+491.0%
Q3 24	-34.7%	-46.3%
Q4 24	-34.7%	-46.3%
Q1 25	-8.3%	-17.1%
Q2 25	-8.3%	-17.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 18	$350.5K	5.6%
Q4 19	$691.3K	9.6%
Q2 20	$797.5K	13.2%
Q4 20	$709.0K	6.9%
Q4 21	$440.8K	2.1%
Q4 22	-$432.4K	-1.8%
Q1 23	$574.3K	2.8%
Q2 23	$574.3K	2.8%
Q3 23	-$574.3K	-3.1%
Q4 23	-$574.3K	-3.1%
Q1 24	$0	0.0%
Q2 24	$0	0.0%
Q3 24	$0	0.0%
Q4 24	$0	0.0%
Q1 25	$0	0.0%
Q2 25	$0	0.0%

OpEx Breakdown

Quarter	G&A	S&M
Q3 21	$13M	$3M
Q4 21	$13M	$3M
Q1 22	$10M	$2M
Q2 22	$10M	$2M
Q3 22	$13M	$3M
Q4 22	$13M	$3M
Q1 23	$11M	$2M
Q2 23	$11M	$2M
Q3 23	$12M	$2M
Q4 23	$13M	$2M
Q1 24	$10M	$2M
Q2 24	$10M	$2M
Q3 24	$19M	$2M
Q4 24	$19M	$2M
Q1 25	$9M	$2M
Q2 25	$9M	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 21	$23M	$0	$23M
Q4 21	$23M	$0	$23M
Q1 22	$11M	$0	$11M
Q2 22	$11M	$0	$11M
Q3 22	$23M	$0	$23M
Q4 22	$23M	$0	$23M
Q1 23	$36M	$0	$36M
Q2 23	$36M	$0	$36M
Q3 23	$8M	$0	$8M
Q4 23	$8M	$0	$8M
Q1 24	$17M	$31M	$48M
Q2 24	$17M	$31M	$48M
Q3 24	$32M	$20M	$51M
Q4 24	$32M	$20M	$51M
Q1 25	$26M	$0	$26M
Q2 25	$26M	$0	$26M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 21	146K	0.0%	-0.6%
Q4 21	146K	0.0%	-0.6%
Q1 22	146K	0.0%	0.0%
Q2 22	146K	0.0%	0.0%
Q3 22	146K	0.0%	0.0%
Q4 22	146K	0.0%	0.0%
Q1 23	146K	0.0%	0.0%
Q2 23	146K	0.0%	0.0%
Q3 23	146K	0.0%	0.0%
Q4 23	146K	0.0%	0.0%
Q1 24	146K	0.0%	0.0%
Q2 24	146K	0.0%	0.0%
Q3 24	146K	+0.0%	+0.0%
Q4 24	146K	0.0%	+0.0%
Q1 25	146K	0.0%	+0.0%
Q2 25	146K	0.0%	+0.0%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 21	$25.1K	851
Q4 21	$22.0K	972
Q1 22	$10.8K	972
Q2 22	$10.8K	972
Q3 22	$24.6K	972
Q4 22	$26.1K	918
Q1 23	$22.6K	918
Q2 23	$22.6K	918
Q3 23	$20.1K	918
Q4 23	$25.4K	727
Q1 24	$22.0K	727
Q2 24	$22.0K	727
Q3 24	$16.6K	727
Q4 24	$20.3K	595
Q1 25	$24.6K	595
Q2 25	$24.6K	595

Revenue / Employee